- Home
- SNGX vs AEMD Comparison
SNGX vs AEMD Comparison
Compare SNGX & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- AEMD
- Stock Information
- Founded
- SNGX 1987
- AEMD 1984
- Country
- SNGX United States
- AEMD United States
- Employees
- SNGX N/A
- AEMD N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- AEMD Medical/Dental Instruments
- Sector
- SNGX Health Care
- AEMD Health Care
- Exchange
- SNGX Nasdaq
- AEMD Nasdaq
- Market Cap
- SNGX 7.5M
- AEMD 2.1M
- IPO Year
- SNGX 1987
- AEMD N/A
- Fundamental
- Price
- SNGX $3.74
- AEMD $0.35
- Analyst Decision
- SNGX
- AEMD Strong Buy
- Analyst Count
- SNGX 0
- AEMD 1
- Target Price
- SNGX N/A
- AEMD $7.00
- AVG Volume (30 Days)
- SNGX 116.0K
- AEMD 3.6M
- Earning Date
- SNGX 08-09-2024
- AEMD 08-14-2024
- Dividend Yield
- SNGX N/A
- AEMD N/A
- EPS Growth
- SNGX N/A
- AEMD N/A
- EPS
- SNGX N/A
- AEMD N/A
- Revenue
- SNGX $494,623.00
- AEMD N/A
- Revenue This Year
- SNGX N/A
- AEMD N/A
- Revenue Next Year
- SNGX $76.64
- AEMD N/A
- P/E Ratio
- SNGX N/A
- AEMD N/A
- Revenue Growth
- SNGX N/A
- AEMD N/A
- 52 Week Low
- SNGX $1.83
- AEMD $0.24
- 52 Week High
- SNGX $32.00
- AEMD $2.90
- Technical
- Relative Strength Index (RSI)
- SNGX 46.76
- AEMD 43.91
- Support Level
- SNGX $3.27
- AEMD $0.33
- Resistance Level
- SNGX $4.67
- AEMD $0.40
- Average True Range (ATR)
- SNGX 0.56
- AEMD 0.10
- MACD
- SNGX 0.04
- AEMD -0.01
- Stochastic Oscillator
- SNGX 22.07
- AEMD 5.06
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical technology company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.